1. Metalloporphyrin Pd(T4) Exhibits Oncolytic Activity and Cumulative Effects with 5-ALA Photodynamic Treatment against C918 Cells
   Brandon Leviskas et al, 2020, International Journal of Molecular Sciences CrossRef
2. Mechanisms of tRNA-derived fragments and tRNA halves in cancer treatment resistance
   Yue Zhang et al, 2020, Biomarker Research CrossRef
3. ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7
   Ting Guo et al, 2019, Cell Death & Disease CrossRef
4. tRNA derived fragments:A novel player in gene regulation and applications in cancer
   Shuangshuang Zhang et al, 2023, Frontiers in Oncology CrossRef
5. Ubiquitin‑specific peptidase 17 promotes cisplatin resistance via PI3K/AKT activation in non‑small cell lung cancer
   Shengchao Zhang et al, 2020, Oncology Letters CrossRef
6. ZEB1 promotes inflammation and progression towards inflammation-driven carcinoma through repression of the DNA repair glycosylase MPG in epithelial cells
   Oriol de Barrios et al, 2019, Gut CrossRef
7. Epithelial–Mesenchymal Transition-Mediated Tumor Therapeutic Resistance
   Zhimin Xu et al, 2022, Molecules CrossRef
8. The EMT transcription factor ZEB1 governs a fitness-promoting but vulnerable DNA replication stress response
   Harald Schuhwerk et al, 2022, Cell Reports CrossRef
9. Naringin targets Zeb1 to suppress osteosarcoma cell proliferation and metastasis
   He Ming et al, 2018, Aging CrossRef
10. The role of the deubiquitinating enzyme DUB3/USP17 in cancer: a narrative review
    Guang-Fei Yang et al, 2021, Cancer Cell International CrossRef
11. Cancer-associated transcription factors in DNA damage response
    Mateusz Kciuk et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef